Context: Polycystic Ovary Syndrome
The Endocrine Society proposed renaming Polycystic Ovary Syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its hormonal + metabolic nature.
Terms
- Polycystic Ovary Syndrome (PCOS): Name mainly focuses on ovarian cysts.
- Polyendocrine Metabolic Ovarian Syndrome (PMOS): Focuses on endocrine hormonal, metabolic, and ovarian dysfunction together.
Disease & Data
- Affected population: ~170 million women globally
- Undiagnosed cases: Up to 70%
Symptoms:
- Irregular menstruation
- High androgen levels
- Acne
- Excess hair growth
- Infertility
Associated diseases:
- Obesity
- Type-2 Diabetes Mellitus
- Hypertension
- Endometrial cancer
Why Renaming Matters?
- Many patients do not have ovarian cysts.
- Current name may delay diagnosis and reinforce stigma.
- New term may improve early diagnosis, awareness, and holistic treatment.
